Clinical Trial Update: Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether oral GS-6615 influences dofetilide-induced QT prolongation, safety, and tolerability in healthy adults. The trial, sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome

Drugs mentioned

• GS-6615

Snippet

Sponsor: Gilead Sciences | Conditions: Long QT Syndrome | Phase 1 | Status: COMPLETED